Vaccinex Inc (VCNX)

$5.54 0.0034 (0.06%)

13:01 EDT VCNX Stock Quote Delayed 30 Minutes

VCNX Stock Earnings: Vaccinex Reported Results for Q1 2024

By InvestorPlace Earnings May 16, 2024

Vaccinex just reported results for the first quarter of 2024.

VCNX Stock Earnings: Vaccinex Reported Results for Q4 2023

Why Is Vaccinex (VCNX) Stock Up 26% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

More Articles

Volume:

Previous Close -

Market Cap 365.31M

PE Ratio -46.17

EPS -0.12

Volume (Avg. Vol.) 3,418

Day's Range $5.26 - $5.70

52-Week Range $0.51 - $10.10

Dividend & Yield N/A (N/A)

VCNX Stock Predictions, Articles, and Vaccinex Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Sep 29, 2023

It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news traders need to know about on Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer May 24, 2023

It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Feb 8, 2023

Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday!

Why Is Vaccinex (VCNX) Stock Up 67% Today?

By William White, InvestorPlace Writer Feb 7, 2023

Vaccinex (VCNX) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Feb 7, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!

The 3 Best Biotech Stocks Under $1 to Buy for January

By Dana Blankenhorn, InvestorPlace Contributor Jan 26, 2023

Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jan 27, 2022

Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 18, 2021

Good morning, trader! We're halfway through the week but still going strong with a peek at the biggest pre-market stock movers for Wednesday!

VCNX Stock: 11 Things to Know About Vaccinex and the Deals That Have Shares Soaring

By William White, InvestorPlace Writer Feb 19, 2021

Vaccinex (VCNX) stock is rocketing higher on Friday after following an announcement about multi-project deals with two comapnies.

Vaccinex prices $3.7M PIPE financing (NASDAQ:VCNX)

From Seeking Alpha Feb 7, 2024

Vaccinex announced a $3.7M private placement transaction, featuring a major new investor and participation from existing investors, selling shares and...

Vaccinex files to sell 712,484 shares for holders (NASDAQ:VCNX)

From Seeking Alpha Jan 10, 2024

Vaccinex (VCNX) files prospectus for resale of 712,484 shares of common stock by selling stockholders. Not an offer to sell securities.

Vaccinex slumps 29%, prices $9.6M equity (NASDAQ:VCNX)

From Seeking Alpha Sep 29, 2023

Vaccinex enters securities purchase agreements for the sale of 9.6M shares at $1.00 per share, expected to raise ~$9.6M for drug development in Alzheimer's...

Vaccinex implements reverse stock split to regain Nasdaq compliance (NASDAQ:VCNX)

From Seeking Alpha Sep 22, 2023

Vaccinex (VCNX) announces a 1-for-15 reverse stock split to regain compliance with Nasdaq listing rules, effective September 25.

MarketBeat Week in Review – 2/6 - 2/10

From MarketBeat Feb 11, 2023

Markets are closed the week looking for direction as investors believe a soft landing is not possible and higher interest rates are likely

Vaccinex's CEO, Chairman To Inject $4M To Fund The Lead Program

From Benzinga Jan 28, 2022

Vaccinex Inc (NASDAQ: VCNX) has announced a private placement of approximately 5.9 million at $1.11 per share for

ADVERTISEMENT